For those of you who may have missed the NBC Nightly News last night, there was excellent coverage of Jedd Wolchok, who heads up our Swim Across America Laboratory at Memorial Sloan Kettering. As most of you know, last year, the SAA Lab was responsible for developing ipilumumab, the first melanoma drug, to be approved by the FDA in over 13 years.
First melanoma drug in 13 years: SAA lab at Sloan Kettering
Jedd and his team are now taking that drug and in combination with radiation seeing even more promising results and hopes that the same approach they are doing for melanoma could work with kidney, lung and other cancers.
Jedd, we are so proud to continue to support all the incredible research that you and your team are doing at MSK. Please pass along our congratulations to your team and keep us in the loop on your further discoveries! You are doing incredible work!
Everyone, please take time to watch and read the attached link below…..and feel free to forward it along to your local committees.
DISCOVERIES LIKE THIS ARE WHY WE SWIM AND DO WHAT WE DO!
Swim Across America Executive Director